Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FH3K1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,871
Award facts
- Contract value 100% obligated
- $9,871.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a contract ceiling value of $9,871.31. The award, dated September 26, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, is well-positioned to fulfill this requirement given its extensive experience delivering brand-name and generic medications to federal healthcare systems. The Ozempic procurement supports DLA's mission to supply critical medications to military and veteran healthcare systems. As a major pharmaceutical distributor registered in the System for Award Management (SAM.gov), AmerisourceBergen maintains a comprehensive portfolio of medical product deliveries across multiple therapeutic domains, with all reviewed contract awards demonstrating competitive award practices and firm fixed-price structures.
Quick answers
Who was awarded contract SPE2DB25FH3K1?
SPE2DB25FH3K1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FH3K1 worth?
The government has obligated $9,871 on SPE2DB25FH3K1.
Is contract SPE2DB25FH3K1 an order under another contract?
Yes. SPE2DB25FH3K1 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH3K1 competed?
The extent of competition for SPE2DB25FH3K1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award